CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Randomized, Double-Blind, Placebo-Controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple-Doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05027269
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-09-29T00:06:11.960982+00:00
Published At: 2026-09-28T00:00:00+00:00
Record Updated At: 2026-09-28
Results Posted At: 2026-09-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["DM1", "Myotonic Dystrophy 1", "Myotonic Dystrophy", "Myotonic Dystrophy Type 1 (DM1)", "Dystrophy Myotonic", "Myotonic Disorders", "Steinert Disease", "Myotonic Muscular Dystrophy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-09-28"
protocolSection.identificationModule.nctId: "NCT05027269"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-Blind, Placebo-Controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple-Doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-09-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.